SecSonar.com

Dr. Reddy's Laboratories Limited (RDY)

Dr. Reddy's Laboratories Limited at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Dr. Reddy's Laboratories Limited (RDY) is a Drug Manufacturers - Specialty & Generic company based in IN with a market capitalization of $11.4B. Revenue grew 8.6% year-over-year and the company generated $336.4M in free cash flow. This page tracks RDY's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

IN · 27.05K employees · IPO Apr 11, 2001

Valuation

Valuation & price

$13.61 · as of May 17, 2026 · -11.5% vs 52w high

0.3

P/E ratio

Latest-FY diluted EPS

0.03

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$15.08$13.77$12.46Jul 25Dec 25Jun 26Jul 7, 25$15.08Jul 9, 25$14.76Jul 11, 25$14.51Jul 15, 25$14.53Jul 17, 25$14.69Jul 21, 25$14.55Jul 23, 25$14.60Jul 25, 25$14.67Jul 29, 25$14.76Jul 31, 25$14.22Aug 4, 25$13.79Aug 6, 25$13.33Aug 8, 25$13.80Aug 12, 25$13.91Aug 14, 25$14.11Aug 19, 25$14.18Aug 21, 25$14.42Aug 25, 25$14.46Aug 27, 25$14.24Aug 29, 25$14.20Sep 3, 25$14.19Sep 5, 25$14.34Sep 9, 25$14.58Sep 11, 25$14.73Sep 15, 25$14.63Sep 17, 25$14.86Sep 19, 25$14.87Sep 23, 25$14.51Sep 25, 25$14.16Sep 29, 25$13.97Oct 2, 25$14.07Oct 6, 25$14.09Oct 8, 25$13.99Oct 10, 25$14.34Oct 14, 25$13.97Oct 16, 25$14.22Oct 20, 25$14.75Oct 22, 25$14.87Oct 24, 25$14.58Oct 28, 25$14.60Oct 30, 25$13.45Nov 3, 25$13.41Nov 5, 25$13.40Nov 7, 25$13.46Nov 11, 25$13.81Nov 14, 25$13.94Nov 18, 25$14.02Nov 20, 25$13.90Nov 24, 25$13.66Nov 26, 25$13.99Dec 1, 25$13.94Dec 3, 25$14.13Dec 5, 25$14.19Dec 9, 25$13.82Dec 11, 25$14.09Dec 15, 25$14.09Dec 17, 25$13.93Dec 19, 25$14.18Dec 23, 25$14.23Dec 26, 25$14.16Dec 31, 25$14.04Jan 5, 26$13.82Jan 7, 26$13.68Jan 9, 26$13.40Jan 13, 26$13.22Jan 15, 26$13.09Jan 20, 26$12.94Jan 22, 26$13.71Jan 26, 26$13.78Jan 28, 26$13.32Jan 30, 26$13.42Feb 3, 26$13.81Feb 5, 26$13.97Feb 9, 26$14.18Feb 11, 26$14.21Feb 17, 26$14.40Feb 19, 26$14.35Feb 23, 26$14.70Feb 25, 26$14.60Feb 27, 26$14.38Mar 3, 26$14.25Mar 5, 26$14.27Mar 9, 26$14.39Mar 11, 26$14.54Mar 13, 26$14.13Mar 17, 26$14.19Mar 19, 26$14.14Mar 23, 26$13.69Mar 25, 26$13.87Mar 27, 26$13.48Apr 1, 26$13.47Apr 6, 26$13.14Apr 8, 26$13.24Apr 10, 26$13.31Apr 14, 26$13.13Apr 16, 26$13.06Apr 20, 26$13.09Apr 22, 26$12.84Apr 24, 26$13.67Apr 28, 26$14.03Apr 30, 26$13.64May 4, 26$13.35May 6, 26$13.46May 8, 26$13.23May 12, 26$12.46May 15, 26$13.61May 19, 26$13.45May 21, 26$13.55May 26, 26$13.75May 28, 26$13.52Jun 1, 26$13.26Jun 3, 26$13.02Jun 5, 26$13.24Jun 9, 26$13.37Jun 11, 26$13.36Jun 15, 26$13.33Jun 17, 26$13.15Jun 22, 26$13.91Jun 24, 26$14.66Jun 30, 26$14.52
$12.4652-week range$15.38
Loading valuation history…

Fundamentals

Key fundamentals

$11.4B

Market cap

8.6%

Revenue growth (YoY)

52.8%

Gross margin

$336.4M

Free cash flow (USD)

-$10.3B

Net debt

Net cash position

-0.1%

Share dilution

5/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2017 → 2026

FY 2017$140.8BFY 2018$142.0BFY 2019$153.9BFY 2020$174.6BFY 2021$2.6BFY 2022$214.4BFY 2023$245.9BFY 2024$279.2BFY 2025$325.5BFY 2026$353.5B
$140.8B$353.5B

Free cash flow by year

2017 → 2026

FY 2017$-19.5BFY 2018$7.0BFY 2019$21.2BFY 2020$23.7BFY 2021$23.1BFY 2022$9.1BFY 2023$40.0BFY 2024$18.0BFY 2025$12.0BFY 2026$32.1B
-$19.5B$32.1B

Gross margin by year

2022 → 2026

FY 202253.1%FY 202356.7%FY 202458.6%FY 202558.5%FY 202652.8%
53.1%52.8%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 6-K filed Jul 1, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • Annual reportAnnual Report FiledJul 1, 2026Filing
  • 6-K filingRegulatory UpdateJul 1, 2026Filing
  • 6-K filingRegulatory UpdateJun 30, 2026Filing
  • 6-K filingRegulatory UpdateJun 30, 2026Filing
  • 6-K filingRegulatory UpdateJun 30, 2026Filing
  • 6-K filingRegulatory UpdateJun 26, 2026Filing
  • 6-K filingEquity Shares AllotmentJun 22, 2026Filing
  • 6-K filingAnnual General Meeting NoticeJun 22, 2026Filing
  • Quarterly reportQuarterly Report FiledJun 22, 2026Filing
  • 6-K filingProduct Launch AnnouncementJun 15, 2026Filing

Questions

Frequently asked questions

What is Dr. Reddy's Laboratories Limited's market cap?

Dr. Reddy's Laboratories Limited (RDY) has a market capitalization of $11.4B.

What is RDY's P/E ratio?

RDY trades at a price-to-earnings ratio of 0.3, based on its latest fiscal-year diluted earnings per share and the most recent cached price.

What is RDY's price-to-book (P/B) ratio?

RDY trades at 0.03 times book value per share.

Are insiders buying RDY stock?

SEC Form 4 filings show no open-market insider buys at Dr. Reddy's Laboratories Limited in the last 90 days (0 sells).

Same arena

Related companies in Drug Manufacturers - Specialty & Generic

ELAN

Elanco Animal Health Incorporated

$12B

LNTH

Lantheus Holdings, Inc.

$6.5B

INDV

Indivior Pharmaceuticals Inc

$4.5B

AMRX

Amneal Pharmaceuticals, Inc.

$4.2B

VTRS

Viatris Inc.

$18.8B

SUPN

Supernus Pharmaceuticals, Inc.

$2.7B

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.